Increase of Soluble Programmed Cell Death Ligand 1 in Patients with Chronic Hepatitis C

Objectives: To determine whether the soluble programmed cell death ligand 1 (sPD-L1) levels in patients with chronic hepatitis C (CHC) are associated with the clinical features of the disease and the efficacy of treatment, including interferon (IFN)-α. Methods: We investigated the sPD-L1 levels in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamagiwa, Satoshi, Ishikawa, Toru, Waguri, Nobuo, Sugitani, Soichi, Kamimura, Kenya, Tsuchiya, Atsunori, Takamura, Masaaki, Kawai, Hirokazu, Terai, Shuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441031/
https://www.ncbi.nlm.nih.gov/pubmed/28539815
http://dx.doi.org/10.7150/ijms.18784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441031/
https://www.ncbi.nlm.nih.gov/pubmed/28539815
http://dx.doi.org/10.7150/ijms.18784

Ejemplares similares